• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GNP
Click for more information
0.40% $2.49

GENUSPLUS GROUP LTD - Charts / Financials

Market Cap $442.5M  ! watchlist Created with Sketch. Add to my watchlist
Industrials Conglomerates

GenusPlus Group Ltd is an Australia-based specialist power and communications... GenusPlus Group Ltd is an Australia-based specialist power and communications infrastructure and services provider. The Company and its subsidiaries' principal activities include the construction and maintenance of transmission and distribution power lines and substations servicing the Western Australian, Queensland, New South Wales and Tasmanian power networks, as well as providing specialist engineering, testing and commissioning services to the electrical and communications industries. Its segments include Infrastructure, Communications and Industrial Services. Its Infrastructure segment offers a range of services, including planning, designing, constructing, operating, testing, maintaining, managing and decommissioning power network assets. Its Communications segment is engaged in constructing networks, to maintain and upgrade existing infrastructure. Its Industrial Services segment provides fully integrated electrical and instrumentation (E&I) and mechanical services.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 07/10/2024 (20 minute delay) ?
Day
Open $2.56   Day High $2.57   Day Low $2.46
Daily Volume 131200
Bids   Sellers
Number Price Volume   Number Price Volume
1 $2.49 1177   2 $2.52 3508

Data source: Refinitiv

(20min delay)
Last
$2.49 		Change
0.010(0.40%) 		Mkt cap ! $442.5M
Open High Low Value Volume
$2.56 $2.57 $2.46 $331.4K 131.2K

Buyers (Bids)

No. Vol. Price($)
1 1177 $2.49
 

Sellers (Offers)

Price($) Vol. No.
$2.52 3508 2
View Market Depth
Last trade - 16.10pm 07/10/2024 (20 minute delay) ?
Last
$2.51 		  Change
0.010 ( 1.62 %)
Open High Low Volume
$2.56 $2.56 $2.46 11540
Last updated 15.59pm 07/10/2024 ?

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage
Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome Neuren has confirmed it's received "positive" FDA responses for its Phase III trial to treat children with Phelan-McDermid syndrome.
Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial.
Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program Arika Resources Ltd has received commitments from investors in support of a Placement worth $3.2 million to support gold exploration in WA
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.